Stereotactic Aspiration for Primary Brainstem Hemorrhage Based on 'Zhe-er Classification'
A Descriptive Research on the Effect of Primary Brainstem Hemorrhage Stereotactic Aspiration Based on 'Zhe-er Classification'
1 other identifier
observational
340
1 country
1
Brief Summary
The purpose of this study is to determine the benefit of stereotaxic aspiration for patients with primary brainstem hemorrhage with the guidance of 'Zhe-er Classification'
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2020
CompletedFirst Submitted
Initial submission to the registry
May 31, 2021
CompletedFirst Posted
Study publicly available on registry
June 2, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2021
CompletedJune 2, 2021
May 1, 2021
8 months
May 31, 2021
May 31, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Survival events
Survival events include death, deterioration/recovery of nervous function
1 year after hemorrhage
Study Arms (2)
Patients received stereotaxic aspiration
No new/additional patients will be enrolled within this project. Only retrospective data will be collected on survival time and life quality
Patients received conservative therapy
No new/additional patients will be enrolled within this project. Only retrospective data will be collected on survival time and life quality
Interventions
No new/additional patients will be enrolled within this project.
Eligibility Criteria
All patients with primary brainstem hemorrhage who receive stereotaxic aspiration or conservative therapy from 3/2014 to 10/2020 in 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
You may qualify if:
- Patients undergoing a stereotaxic aspiration or conservative therapy from 3/2014 to 10/2020 in 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
You may not qualify if:
- patients with secondary brainstem hemorrhage due to blood vessel malformation, trauma, or malignancies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jianmin Zhang
Hangzhou, Zhejiang, 310000, China
Related Publications (1)
Zhou J, Wang R, Mao J, Gu Y, Shao A, Liu F, Zhang J. Prognostic models for survival and consciousness in patients with primary brainstem hemorrhage. Front Neurol. 2023 Feb 23;14:1126585. doi: 10.3389/fneur.2023.1126585. eCollection 2023.
PMID: 36908614DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Jianmin Zhang, MD
2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 31, 2021
First Posted
June 2, 2021
Study Start
November 1, 2020
Primary Completion
June 30, 2021
Study Completion
June 30, 2021
Last Updated
June 2, 2021
Record last verified: 2021-05
Data Sharing
- IPD Sharing
- Will not share